Portage Biotech (PRTG) announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a ...
Combining PORT-6 and PORT-7 for a More Comprehensive Immunotherapy Approach ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果